Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
Alternative names
autologous mesenchymal stem cell-derived neural progenitors (1 trial)
cefepime (maxipeme) (1 trial)
meropenem (merrem) (1 trial)
piperacillin (pipracil) (1 trial)
tazobactam (Zosyn) (1 trial)
vancomycin (Vancocin) (1 trial)
Multiple Sclerosis (Phase 1)
Multiple Sclerosis, Chronic Progressive (Phase 1)
Neoplasm Metastasis (Phase 1)
Sclerosis (Phase 1)
Trials (2 total)
Trial APIs (6 total)